Therapeutic potential of ketotifen in irritable bowel syndrome (IBS) may involve changes in mast cells at sites beyond the rectum
- PMID: 20921205
- DOI: 10.1136/gut.2010.225078
Therapeutic potential of ketotifen in irritable bowel syndrome (IBS) may involve changes in mast cells at sites beyond the rectum
Comment on
-
The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome.Gut. 2010 Sep;59(9):1213-21. doi: 10.1136/gut.2010.213108. Epub 2010 Jul 21. Gut. 2010. PMID: 20650926 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources